Factors related to transfusion in very low birthweight infants treated with erythropoietin.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Archives of Disease in Childhood: Fetal and Neonatal Edition

• Publication date

  1996-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/fn.74.3.F182PMID 8777681PMCID PMC2528356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial.

  1995cited by this paper
• Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.

  1995cited by this paper
• Literature Reviews: Neonatal-Perinatal Medicine: The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth Weight Infants Maier RF, Obladen N, Scigalla P, et al. N Engl J Med. 1994;330:1173-1178

  1995cited by this paper
• The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.

  1994cited by this paper
• Early Rise in Serum Concentration of Transferrin Receptor Induced by Recombinant Human Erythropoietin in Very-Low-Birth-Weight Infants

  1994cited by this paper
• Erythropoietin levels during theophylline treatment in premature infants.

  1994cited by this paper
• Erythropoiesis of very low‐birth‐weight infants dependent on prenatal growth rate and protein status

  1994cited by this paper
• Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.

  1994cited by this paper
• In Which Neonates Does Early Recombinant Human Erythropoietin Treatment Prevent Anemia of Prematurity? Results of a Randomized, Controlled Study

  1993cited by this paper
• National survey of neonatal transfusion practices: I. Red blood cell therapy.

  1993cited by this paper
• Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects.

  1993cited by this paper
• Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.

  1993cited by this paper
• Early treatment of premature infants with recombinant human erythropoietin

  1993cited by this paper
• Umbilical cord clamping and preterm infants: a randomised trial.

  1993cited by this paper
• Double blind trial of recombinant human erythropoietin in preterm infants.

  1993cited by this paper
• Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.

  1992cited by this paper
• Optimization of the blood for oxygen transport and tissue perfusion in critical care.

  1992cited by this paper
• Protein deficiency impairs erythropoiesis in rats by reducing serum erythropoietin concentration and the population size of erythroid precursor cells.

  1992cited by this paper
• Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.

  1992cited by this paper
• Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.

  1991cited by this paper
• Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity

  1991cited by this paper
• Transfusion therapy in neonates.

  1991cited by this paper
• Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

  1991cited by this paper
• Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.

  1991cited by this paper
• Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation.

  1990cited by this paper
• Prediction of the need for transfusion during anemia of prematurity.

  1990cited by this paper
• Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

  1990cited by this paper
• Methods for measuring erythropoietin and erythropoietin antibodies using ELISA technique.

  1990cited by this paper
• Blood sampling in very low birth weight infants receiving different levels of intensive care

  1988cited by this paper
• Lessons from the anemia of prematurity.

  1987cited by this paper
• Postnatal changes in fetal hemoglobin, oxygen affinity and 2,3-diphosphoglycerate in previously transfused preterm infants.

  1985cited by this paper

• Survey on clinical use and non-use of recombinant human erythropoietin in European neonatal units

  2020cites this paper
• Gut and cerebral perfusion and oxygenation in preterm infants receiving blood transfusion

  2017cites this paper
• [Single-donor protocol: Transfusion practices and multiple transfusion risk factors in neonatal intensive care unit].

  2016cites this paper
• Protocole donneur unique : pratiques transfusionnelles et facteurs de risque des transfusions multiples en réanimation néonatale

  2016cites this paper
• Research article Invasive versus noninvasive hemoglobin measurement by pulse CO-Oximeter in neonates admitted to NICU

  2014cites this paper
• Influence of Shielding TPN From Photooxidation on the Number of Early Blood Transfusions in ELBW Premature Neonates

  2012cites this paper
• Optimization of anemia management in preterm infants

  2012cites this paper
• Is erythropoietin an acceptable treatment modality for routine use in preventing anaemia of prematurity

  2011cites this paper
• Factores de riesgo implicados en la necesidad de transfusión sanguínea en recién nacidos de muy bajo peso tratados con eritropoyetina

  2010cites this paper
• [Risk factors involved in the need for blood transfusion in very low birth weight newborns treated with erythropoietin].

  2010cites this paper
• Spectroscopic Noninvasive Measurement of Hemoglobin Compared with Capillary and Venous Values in Neonates

  2009cites this paper
• Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia

  2009cites this paper
• Cellular lifespan based pharmacodynamic analysis of erythropoiesis

  2009cites this paper
• When to transfuse preterm babies

  2008cites this paper
• Recombinant Erythropoietin for Anaemia of Prematurity—When Should Treatment Start?

  2007cites this paper
• Erythropoetin in der Neonatologie

  2007cites this paper
• Anämien des Früh- und Neugeborenen

  2006cites this paper
• Prediction of transfusions in extremely low‐birthweight infants in the erythropoietin era

  2006cites this paper
• Neonatal Hematology: Transfusion practices

  2005cites this paper
• Neonatal Hematology: Frontmatter

  2005cites this paper
• Strict red blood cell transfusion guideline reduces the need for transfusions in very‐low‐birthweight infants in the first 4 weeks of life: a multicentre trial

  2005cites this paper
• Neonatal Hematology: Anemia of prematurity and indications for erythropoietin therapy

  2005cites this paper
• Measurement of Transcutaneous Hemoglobin Concentration by Noninvasive White-Light Spectroscopy in Infants

  2005cites this paper
• Randomized Trial of Liberal Versus Restrictive Guidelines for Red Blood Cell Transfusion in Preterm Infants

  2005cites this paper
• Post-transfusional hepatitis in neonates hospitalized in a Neonatal Intensive Care Unit.

  2004cites this paper
• Oral iron supplementation in preterm infants treated with erythropoietin

  2004cites this paper
• Erythropoïétine humaine recombinante : analyse d'une politique de prescription dans une population hospitalière de nouveau-nés de faible poids de naissance

  2003cites this paper
• Blood Transfusion Practices in Neonatal Unit

  2003cites this paper
• [Recombinant human erythropoietin: analysis of a policy of treatment in an hospital based population of very-low-birthweight infants].

  2003cites this paper
• Hämatologische Referenzwerte von Frühgeborenen unter 1500 g Geburtsgewicht

  2002cites this paper
• Iron status and the treatment of the anemia of prematurity.

  2002cites this paper
• A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country.

  2002cites this paper
• Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?

  2001cites this paper
• Glucose monitoring with long-term subcutaneous microdialysis in neonates.

  2001cites this paper
• Hematocrit Correlates Well with Circulating Red Blood Cell Volume in Very Low Birth Weight Infants

  2001cites this paper
• Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.

  2001cites this paper
• Adaptive responses during anemia and its correction in lambs.

  2000cites this paper
• A randomised controlled trial of delayed cord clamping in very low birth weight preterm infants

  2000cites this paper
• Prospective Randomized Trial of Early Versus Late Enteral Iron Supplementation in Infants With a Birth Weight of Less Than 1301 Grams

  2000cites this paper
• Venous and Arterial Hematologic Profiles of Very Low Birth Weight Infants

  2000cites this paper
• Pathophysiology, Diagnosis, and Prevention of Neonatal Anemia

  2000cites this paper
• Temporal variation in serum nitrite levels in rats and mice.

  1999cites this paper
• Red blood cell transfusions in the newborn

  1999cites this paper
• Low degree of regionalization and high transfusion rates in very low birthweight infants: A survey in Germany

  1998cites this paper
• Recombinant erythropoietin in treatment of the premature newborn

  1998cites this paper
• Évolution et évaluation des pratiques transfusionnelles dans une population de nouveau-nés de moins de 33 semaines d'âge gestationnel

  1998cites this paper
• Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants

  1998cites this paper
• High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group.

  1998cites this paper
• -Development and evaluation of transfusion practices in a population of newborn infants less than 33 weeks gestational age.

  1998cites this paper
• Methods for reduction of perioperative bleeding.

  1998cites this paper
• Practice variation: implications for neonatal red blood cell transfusions.

  1998cites this paper
• Recombinant Human Erythropoietin as a Treatment for Anemia of Prematurity

  1997cites this paper
• Predicting red blood cell transfusions in very low birth weight infants based on clinical risk factors.

  1997cites this paper